3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Breast
1
Conditions
Condylomata Acuminata
3
Neoplasms
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Keratosis, Actinic
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Wounds and Injuries
1
Virus Diseases
1
Usual Type Vulval Intraepithelial Neoplasia (uVIN)
1
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Urinary Bladder Diseases
1
Squamous Intraepithelial Lesions
1
Skin Neoplasms
1
Sexually Transmitted Diseases
1
Parapsoriasis
1
Papillomavirus Infections
1
Non-Muscle Invasive Bladder Neoplasms
1
Non-Melanoma Skin Cancers
1
Lymphoma, Follicular
1
Keratosis, Seborrheic
1
Hypogonadism
1
Hemangioma, Cavernous
1
Hemangioma
1
Fatigue
1
Exanthema
1
Eunuchism
1
Dermatitis, Contact
1
Interventions
Morphine
2
resiniferatoxin
1
incobotulinumtoxinA
1
fulranumab
1
cannabichromene
1
alvimopan
1
Tablets
1
Surveys and Questionnaires
1
Standard of Care
1
Pain Management
1
Oxycodone
1
Occupational Therapy
1
Massage
1
Lidocaine
1
Lenalidomide
1
Ketamine
1
Gels
1
Fentanyl
1
Dronabinol
1
Cannabidiol
1
Animal Assisted Therapy
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Cancer Pain
×
Gels
×
Clear all
NCT05800834
2023-09-28
MorphineGEL
Instituto Nacional de Cancer, Brazil
Phase 2
Unknown
106 enrolled